Home
Scholarly Works
Rivaroxaban 2.5 mg Twice Daily Plus Aspirin...
Journal article

Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis

Authors

Pogosova N; Bosch J; Bhatt DL; Fox KAA; Connolly SJ; Alings M; Verhamme P; Muehlhofer E; Shestakovska O; Yusuf S

Journal

Circulation, Vol. 145, No. 25, pp. 1875–1877

Publisher

Wolters Kluwer

Publication Date

June 21, 2022

DOI

10.1161/circulationaha.122.059405

ISSN

0009-7322

Contact the Experts team